Technical Data
T0294
TACI, Recombinant, Human (Transmembrane activator and CAML interactor)
5ug
20ug
Molecular Biology Storage: -20CShipping: RT
Human TACI (Transmembrane activator and CAML interactor) is a newly discovered member of the TNF receptor superfamily. TACI is a receptor for BAFF (BlyS) and APRIL. Recombinant human TACI is a soluble 17.0kD protein containing 153 amino acid residues.

Biological Activity:
Determined by its ability to block human BAFF induced T2B cell survival using a concentration range of 1-3ug/ml.

AA Sequence:
MSGLGRSRRG GRSRVDQEER FPQGLWTGVAMRSCPEEQYWDPLLGTCMSC KTICNHQSQR TCAAFCRSLS CRKEQGKFYDHLLRDCISCA SICGQHPKQC AYFCENKLRS PVNLPPELRRQRSGEVENNS DNSGRYQGLEHRGSEASPALPGLKLSADQV

Storage and Stability:
Lyophilized powder may be stored at -20C. Reconstitute to nominal volume by adding ddH20 and a carrier protein. Aliquot and store at -20C. Reconstituted product is stable for 3 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Country of Origin: USA

Molecular Weight:
17.8kD
Source: E. coli
Purity: 98% by SDS-PAGE and HPLC analyses. Endotoxin: 0.1ng/ug (1EU/ug)
Form: Supplied as a lyophilized powder from 10mM sodium citrate, pH 4.0, 150mM sodium chloride. Reconstitution: Reconstitute with ddH20 and a carrier protein to a concentration of 0.1-1mg/ml.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.